Bristol-Myers Squibb
BMY
BMY
1,744 hedge funds and large institutions have $75B invested in Bristol-Myers Squibb in 2018 Q1 according to their latest regulatory filings, with 128 funds opening new positions, 593 increasing their positions, 777 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $71.6B → $75B (+$3.36B)
1% more funds holding
Funds holding: 1,733 → 1,744 (+11)
24% less repeat investments, than reductions
Existing positions increased: 593 | Existing positions reduced: 777
Holders
1,744
Holding in Top 10
59
Calls
$2.17B
Puts
$1.11B
Top Buyers
| 1 | +$624M | |
| 2 | +$198M | |
| 3 | +$197M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$194M |
| 5 |
Goldman Sachs
New York
|
+$191M |
Top Sellers
| 1 | -$407M | |
| 2 | -$198M | |
| 3 | -$127M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$125M |
| 5 |
JP Morgan Chase
New York
|
-$124M |